• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一项前瞻性、随机、对照研究比较了两种剂量重组人绒毛膜促性腺激素在高体重指数妇女血清和卵泡液中的效果。

A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index.

机构信息

Istanbul Memorial Hospital, Istanbul, Turkey.

出版信息

Fertil Steril. 2010 Apr;93(6):2084-7. doi: 10.1016/j.fertnstert.2009.08.026. Epub 2009 Sep 26.

DOI:10.1016/j.fertnstert.2009.08.026
PMID:19782346
Abstract

This prospective, randomized, controlled study compares the efficiency of 250 microg or 500 microg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (>or=26 kg/m(2)) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.

摘要

本前瞻性、随机、对照研究比较了重组 hCG 250μg 或 500μg 在血清和卵泡液（FF）水平以及体质量指数（BMI）≥26kg/m²的女性接受辅助生殖治疗（ART）中的妊娠率（PR）方面的效率。两组的治疗结局相似。

相似文献

1
A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index.一项前瞻性、随机、对照研究比较了两种剂量重组人绒毛膜促性腺激素在高体重指数妇女血清和卵泡液中的效果。
Fertil Steril. 2010 Apr;93(6):2084-7. doi: 10.1016/j.fertnstert.2009.08.026. Epub 2009 Sep 26.
2
BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality.与 BMI 相关的接受辅助生殖治疗的女性卵泡液的代谢成分及其对卵母细胞和胚胎质量的影响。
Hum Reprod. 2012 Dec;27(12):3531-9. doi: 10.1093/humrep/des350. Epub 2012 Sep 27.
3
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.体外受精过程中重组人绒毛膜促性腺激素与尿源性人绒毛膜促性腺激素的血清和卵泡液激素水平比较
Fertil Steril. 2008 Dec;90(6):2133-7. doi: 10.1016/j.fertnstert.2007.10.015. Epub 2008 Jan 4.
4
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.使用不同剂量人绒毛膜促性腺激素触发最终卵母细胞成熟：一项在接受促性腺激素释放激素拮抗剂和重组促卵泡激素治疗的多囊卵巢综合征患者中的随机试点研究
Fertil Steril. 2007 Nov;88(5):1382-8. doi: 10.1016/j.fertnstert.2006.12.058. Epub 2007 Apr 18.
5
Comparison of two doses of recombinant hcg for oocyte maturation in obese women (BMI > or = 30) undergoing assisted reproductive techniques.
Ginekol Pol. 2013 Jul;84(7):603-8. doi: 10.17772/gp/1611.
6
IL-18 and IL-18 binding protein concentrations in serum and ovarian follicular fluid do not affect in vitro fertilization outcomes in obese, overweight, and non-obese patients.血清和卵巢卵泡液中白细胞介素-18（IL-18）及白细胞介素-18结合蛋白的浓度不影响肥胖、超重及非肥胖患者的体外受精结局。
J Reprod Immunol. 2009 Jan;79(2):211-4. doi: 10.1016/j.jri.2008.10.002. Epub 2008 Dec 20.
7
Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.接受促性腺激素释放激素激动剂或人绒毛膜促性腺激素诱导排卵的女性卵泡液的激素特征。
Hum Reprod. 2006 Aug;21(8):2126-30. doi: 10.1093/humrep/del119. Epub 2006 May 8.
8
Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.在体外成熟过程中暴露于人类绒毛膜促性腺激素并不能提高多囊卵巢综合征患者未成熟卵母细胞的成熟率和发育潜能。
Fertil Steril. 2008 Jan;89(1):98-103. doi: 10.1016/j.fertnstert.2007.02.021. Epub 2007 May 24.
9
Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.在接受辅助生殖治疗的排卵诱导女性中诱导最终卵泡成熟和早期黄体化——重组人绒毛膜促性腺激素与尿源性人绒毛膜促性腺激素的比较。欧洲重组人绒毛膜促性腺激素研究组
Hum Reprod. 2000 Jul;15(7):1446-51.
10
Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial.重组人绒毛膜促性腺激素或尿源性人绒毛膜促性腺激素宫腔内人工授精：一项前瞻性随机试验。
Gynecol Endocrinol. 2008 Nov;24(11):644-8. doi: 10.1080/09513590802308107.

引用本文的文献

1
Female BMI and Body Weight Is Not Associated with Oocyte Yield and Maturation in hCG, Agonist or Dual Trigger Cycles: A Large Observational Study including 5000 Cycles.女性体重指数和体重与hCG、激动剂或双重触发周期中的卵母细胞产量及成熟度无关：一项纳入5000个周期的大型观察性研究。
J Clin Med. 2023 May 1;12(9):3249. doi: 10.3390/jcm12093249.
2
Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women.人绒毛膜促性腺激素注射液在肥胖和正常体重女性中的药代动力学。
J Clin Endocrinol Metab. 2014 Apr;99(4):1314-21. doi: 10.1210/jc.2013-4086. Epub 2014 Jan 29.
3
Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial.
比较尿源性和重组 hCG 对行卵胞浆内单精子注射周期的妇女触发排卵的卵母细胞/卵泡比例的疗效：一项随机对照试验。
J Assist Reprod Genet. 2013 Feb;30(2):239-45. doi: 10.1007/s10815-012-9919-3. Epub 2012 Dec 29.